Nasdaq Wint News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq wint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Wint Today - Breaking & Trending Today

Windtree Therapeutics (NASDAQ:WINT) Shares Scheduled to Reverse Split on Monday, April 22nd

Windtree Therapeutics, Inc. (NASDAQ:WINT – Free Report)’s stock is going to reverse split on Monday, April 22nd. The 1-18 reverse split was announced on Monday, April 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, April 22nd. Windtree Therapeutics Trading Down 15.3 % WINT traded down $0.06 […] ....

Millennium Management , Citadel Advisors , Vanguard Group Inc , Windtree Therapeutics Inc , Renaissance Technologies , Envestnet Asset Management Inc , Windtree Therapeutics Company Profile , Windtree Therapeutics , Free Report , Therapeutics Trading Down , Asset Management , Vanguard Group , Get Free Report , Windtree Therapeutics Daily , Nasdaq Wint , Stock Split ,

HC Wainwright Reaffirms "Neutral" Rating for Windtree Therapeutics (NASDAQ:WINT)

HC Wainwright reaffirmed their neutral rating on shares of Windtree Therapeutics (NASDAQ:WINT – Free Report) in a research report report published on Wednesday morning, Marketbeat.com reports. HC Wainwright also issued estimates for Windtree Therapeutics’ Q4 2023 earnings at ($0.94) EPS, FY2023 earnings at ($5.27) EPS and FY2024 earnings at ($0.97) EPS. Windtree Therapeutics Price Performance […] ....

Envestnet Asset Management Inc , Acadian Asset Management , Citadel Advisors , Windtree Therapeutics Company Profile , Windtree Therapeutics Inc , Vanguard Group Inc , Millennium Management , Windtree Therapeutics , Free Report , Get Free Report , Asset Management , Vanguard Group , Windtree Therapeutics Daily , Nasdaq Wint , Reiterated Rating , Hc Wainwright ,

Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Up 540.3% in October

Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 188,900 shares, a growth of 540.3% from the September 30th total of 29,500 shares. Currently, 4.3% of the shares of the company are […] ....

Windtree Therapeutics Inc , Envestnet Asset Management Inc , Renaissance Technologies , Millennium Management , Acadian Asset Management , Virtu Financial , Windtree Therapeutics , Get Free Report , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,

Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Increases By 540.3%

Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 188,900 shares, an increase of 540.3% from the September 30th total of 29,500 shares. Approximately 4.3% of the shares of the stock are […] ....

Envestnet Asset Management Inc , Windtree Therapeutics Inc , Millennium Management , Citadel Advisors , Virtu Financial , Acadian Asset Management , Windtree Therapeutics , Get Free Report , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,